Delivery Order SPE2DB20D1004-SPE2DB21FF9N3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,779.61 for the supply of Jardiance 10 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The $2,613.13 firm fixed-price contract (Delivery Order SPE2DB22FF7Z1) has a completion date of June 17, 2022. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This single-award IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The $24,415.50 firm-fixed-price delivery order, with a completion date of November 2, 2023, does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The $6,839.29 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA) for the supply of Jardiance 10 mg tablets. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 10 mg tablets. The $4,451.64 firm fixed-price delivery order contract has a completion date of January 24, 2024 and was awarded on January 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc., is for the delivery of Jardiance 25 mg tablets. The $2,034.95 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 13, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Jardiance 25 mg tablets to the U.S. government. The contract, with a ceiling value of $13,572.99, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on January 11, 2024, with a completion date of January 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of Jardiance 25 mg tablets. The $1,624.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of June 3, 2022. The award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Jardiance 25 mg tablets to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $92,316.80 firm-fixed-price delivery order has a completion date of January 4, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to support the U.S. Department of Defense and other government healthcare programs. The $16,648.73 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has a completion date of May 7, 2024. The contract covers the delivery of Jardiance 10 mg tablets. This award is not designated as a set-aside contract....
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF9N3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,648.38 for the supply of Jardiance 10 mg tablets. The award was made by the Defense Logistics Agency (DLA) on August 17, 2021, with an ultimate completion date of August 18, 2021. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, as a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving the military, veterans, and other government beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/17/21 |